This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Cronos Group Inc.
11/5/2026
Good morning. My name is Stephanie, and I will be your conference operator today. I would like to welcome everyone to Kronos' 2026 Third Quarter Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Harrison Aaron, Senior Director, Investor Relations and Corporate Development. Please go ahead.
Thank you, Stephanie, and thank you for joining us today to review Kronos' 2026 Q3 Financial and Business Performance. Today, I am joined by our Chairman, President, and CEO, Mike Gorenstein, and our CFO, Anna Shlimak. Kronos issued a news release announcing our financial results this morning, which is filed on our EDGAR and CDAR profiles. This information and the prepared remarks will also be posted on our website under Investor Relations. Before I turn the call over to Mike, let me remind you that we may make forward-looking statements and refer to non-GAAP financial measures during this call. These forward-looking statements are based on management's current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. Factors that could cause actual results to differ materially from expectations are detailed in our earnings materials and our SEC filings that are available on our website, by which any forward-looking statements made during this call are qualified in their entirety. Information about non-GAAP financial measures including are available on our website. Lastly, we will be making statements regarding market share information throughout this conference call, and unless otherwise stated, all market share data is provided by HiFire. We will now make prepared remarks, and then we'll move to a question and answer session. With that, I'll pass it over to Kronos' Chairman, President, and CEO, Mike Gorenstein.
Thanks, Harrison. Kronos delivered an outstanding third quarter. Organically achieving records across net revenue, gross profit, and adjusted EBITDA, reflecting the successful execution of our borderless product strategy across each region in which we operate. Starting with Israel, Kronos delivered its 11th and 2nd quarter of record net revenue, growing 33% year-over-year, or 19% growth, on a constant currency basis, with the Peace Naturals brand reinforcing its leadership position based on pharmacy data collected by Kronos. Our value brand Lit also drove growth in the quarter. Turning to Canada, we delivered record net revenue, with our brands generating 41% year-over-year retail sales growth relative to industry-wide sales growth of 1%. The Spinach brand posted another standout quarter, with its market-leading share gains underscoring the effectiveness of our innovation engine. In Canada, Spinach maintained its number one position in vapes for the third consecutive quarter, The total vape market share expanding to 11.4%. Within the vape cartridge subcategory, Spinach held its number one position for the fourth consecutive quarter, with market share expanding to 12.1%. In the all-in-one vape subcategory, Spinach share expanded to 10.2%, as our Puffer's all-in-one innovation continues to gain market traction. In the third quarter, we continue to leverage our proven flavor development process, introducing two new flavor profiles to the Spinach Vape cartridge line, the Strawberry Banana 1.2 gram vape and the Sweet Citrus Ponce 1 gram liquid diamond vape. We followed this up in October with a reintroduction of the seasonal limited edition Sweet Green Apple 1 gram vape. In edibles, Sour's remained Canada's number one brand for the ninth consecutive quarter, with Market Share rising to 21.8% and Share Within Gummies expanding to 23.6%. In Q3, Sour's by Spinach fully blasted offerings were four of the top seven edibles used in Canada, including the number one edible nationwide, the fully blasted Blue Raspberry Watermelon 10-pack. In September, we expanded the Sours by Spinach product lineup with the launch of the Fully Blasted Blue Raspberry Lemonade Gummies, the brand's first gummies infused with 100% live resin. In October, we introduced the Caramel Green Apple flavor to our Fully Blasted Sours portfolio for the first time, with a limited edition offering available this fall. In flour, Spinach ranked number 3 in Canada, with market share expanded at 6.1%. and the two spinach skews among the top seven selling flower products nationwide. Strong product demand continues to drive tight flower supply, even with the additional capacity from our late 2025 GroCo expansion. In pre-rolls, spinach continued to climb the ranks to number five in Canada, with market share rising to 3.3%. Within infused pre-rolls, spinach ranked sixth, with market share increasing to 3.8%. In traditional free rolls, spinach also ranks 6th, with market share increasing to 3%. Turning to our other international markets outside Israel, we delivered record net revenue, which increased by 7x year-over-year, or from $1.9 million to $13.2 million, led by continued robust demand in Germany. Our expanding international footprint continues to be a meaningful growth driver as we execute our borderless product strategy. In October, we completed our acquisition of Canadalar, the largest adult-use cannabis company in Europe, and I'm excited about what this means for Kronos. The Netherlands is a unique market, and it's different from the adult-use markets we've seen legalized in North America. The retail cannabis framework has existed for nearly 50 years under a policy where coffee shops were tolerated by the government to sell cannabis in a restricted manner and, from the perspective of the consumer, has effectively operated like a legal market that entire time. There's no excise tax policy that disadvantages the legal market. The experiment gives retailers more product formats and the ability to carry more inventory than those in the tolerated market. The experiment prohibits wholesale transactions between growers and solvent-based extraction is not allowed. Retailers within the experiment also compete with stores in the legacy tolerated market in neighboring municipalities, which have fewer available product formats. All of this mitigates some of the volatility we see in other new adult use markets. That said, like every new adult use market, we still expect price compression now that suppliers have had a chance to ramp up and meet demand. But with a base purchase price of less than 3x trailing adjusted EBITDA, we didn't make this acquisition with the expectation of short-term price stability or immediate growth. Despite the 50-year-old coffee shop network, this market is still quite immature. Until the experiment, the supply side had never been tolerated like the retail side, so it hasn't had the benefit of years of sustained investment in R&D and operational efficiencies. And the experiment opens the door to new formats such as vapes and gummies. That is where we think we can add value, by implementing efficiencies from our production experience across Kronos and investing to bring our borderless products to the market. We think that, over time, these investments will compound, as they have in the other markets in which we operate. We believe that upside is amplified by the potential expansion of the experiment in the future. This fits our strategy. Build a portfolio of borderless products and take them into new markets as regulations open. In conclusion, we see three ways this acquisition could deliver asymmetric value over the long term. One, introducing our borderless products and improving operational efficiency. Two, benefiting from the potential expansion of the experiment, which currently covers less than 10% of the population. And three, leveraging the Netherlands as a platform to establish our branded products across Europe. We're very excited about the long-term potential here, and we're just getting started. Now, I'll turn it over to Anna to walk you through our third quarter financial.
You're reading a preview of the CRON Q3 2026 earnings call.
Free account.
Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.
Use this data in your own app
Pull this call's transcript, audio and slides with the Earnings call transcripts API.
See pricing